NeoGenomics Joins Thermo Fisher Scientific's Companion Diagnostic Center of Excellence Program with the Launch of Oncomine Dx Target Test
Press Release
Read More
A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy
Literature
Read More
Lymphadenopathy associated with IgG4-related disease: Diagnosis & differential diagnosis
Literature
Read More
NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials
Press Release
Read More
NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials
Press Release
Read More
NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017
Press Release
Read More